Clinical trial
PET and MRI in the Follow-up of Neoadjuvant Chemotherapy of Breast Cancer
NCT00236275 · Assistance Publique - Hôpitaux de Paris, Other · Completed
Key facts
| NCT number | NCT00236275 |
|---|---|
| Title | PET and MRI in the Follow-up of Neoadjuvant Chemotherapy of Breast Cancer |
| Official title | PET and MRI in the Follow-up of Neoadjuvant Chemotherapy of Breast Cancer |
| Lead sponsor | Assistance Publique - Hôpitaux de Paris, Other |
| Collaborators | Pierre and Marie Curie University |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Breast Cancer |
| Intervention type | Drug |
| Interventions | Fluoro-L-thymidine-(18F) |
| Enrollment | 60 |
| Start date | May 1, 2004 |
| Primary completion | Dec 1, 2007 |
| Completion | Dec 1, 2007 |
| First posted | Oct 12, 2005 |
| Last update posted | May 2, 2011 |
| Countries | France |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: